Results 101 to 110 of about 45,024 (296)

Rare Bleeding Disorders and Bleeding Disorder of Unknown Cause: Current Understanding and Recent Developments

Haemophilia, EarlyView.
ABSTRACT Rare bleeding disorders (RBDs) represent a diverse group of inherited conditions involving coagulation factors or platelets. These conditions, such as Glanzmann thrombasthenia (GT) or severe coagulation factor deficiencies, are uncommon. In contrast, bleeding disorder of unknown cause (BDUC) is a diagnosis of exclusion without an identifiable ...
Alessandro Casini, Robert Klamroth, Bauke Haisma, Dino Mehic, Saskia E. M. Schols   +4 more
wiley   +1 more source

Age Distribution of Abnormal PT and aPTT Test Rates.

, 2015
Age Distribution of Abnormal PT and aPTT Test Rates.
Kathryn McGoldrick (782286), Mario A. Inchiosa Jr. (782284), Ernesto Molmenti (782287), Stephen D. Parker (782289), Jerry L. Stonemetz (782279), Vincent A. Fischetti (57436), Judith Wall (782293), Fahad S. Ahmed (782281), Steven K. Magid (782285), Manu N. Capoor (782278), Sajjad Naqvi (782288), Aryeh Shander (782291), R. Grant Steen (431443), Michael K. Urban (782292), Ahsan Awan (782282), Christof Birkenmaier (782283), John C. Baird (782280), S. M. Pothula (782290)   +17 more
core   +1 more source

PENGARUH LAMA PENUNDAAN DARAH SITRAT PADA SUHU 20±1ºC TERHADAP PEMERIKSAAN ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) [PDF]

, 2020
Latar Belakang : Pemeriksaan Activated Partial Thromboplastin Time (APTT) digunakan untuk menguji pembekuan darah melalui jalur intrinsik dan jalur bersama. Pemeriksaan APTT dengan sampel darah sitrat dan plasma harus segera diperiksa.
Amri Nafitri
core  

Monitoring Extended Half‐Life Factor VIII and IX Concentrates: Performance in Routine Clotting‐and Thrombin Generation Assays

Haemophilia, EarlyView.
ABSTRACT Introduction Monitoring extended half‐life (EHL) factor (F) VIII and FIX products is complex, as discrepant results are obtained in different laboratory assays. Aim To provide an overview on assay accuracy based on a re‐assessment of previously published data as well as laboratory results of EHL spiking experiments for specific factor assays ...
An K. Stroobants, Eva‐Leonne Göttgens, Yvonne M. C. Henskens, Joop H. Jansen, Saskia E. M. Schols, Sanna R. Rijpma   +5 more
wiley   +1 more source

Shortening Activated Partial Tromboplastin Time (APTT) Between Hypertension and Nonhypertension in Diabetic Mellitus Patients with Bevacizumab Intravitreal Injection

IJRETINA (International Journal of Retina), 2019
Introduction : Bevacizumab intravitreal injection could be detectable in plasma that might interfere  the coagulopathy and hemostasis condition.
Anik Ika Winarni, Ni Luh Putu Widyasti, Natalia Christina Angsana, Rizto Wisuda Senuari, Angela Nurini Agni, Agus Supartoto, Muhammad Bayu Sasongko, Haryo Yudono   +7 more
doaj   +1 more source

H&P Findings That Prompt PT and aPTT Testing.

, 2015
H&P Findings That Prompt PT and aPTT Testing.
Kathryn McGoldrick (782286), Mario A. Inchiosa Jr. (782284), Ernesto Molmenti (782287), Stephen D. Parker (782289), Jerry L. Stonemetz (782279), Vincent A. Fischetti (57436), Judith Wall (782293), Fahad S. Ahmed (782281), Steven K. Magid (782285), Manu N. Capoor (782278), Sajjad Naqvi (782288), Aryeh Shander (782291), R. Grant Steen (431443), Michael K. Urban (782292), Ahsan Awan (782282), Christof Birkenmaier (782283), John C. Baird (782280), S. M. Pothula (782290)   +17 more
core   +1 more source

Perioperative Outcomes in Factor XI Deficiency: A Systematic Review

Haemophilia, EarlyView.
ABSTRACT Background Congenital factor XI (FXI) deficiency has a variable bleeding phenotype, and FXI activity alone does not predict perioperative bleeding. Management practices remain heterogeneous, and available evidence derives from case reports, small case series, and retrospective cohorts.
Zainab Al‐Housni, Raeesah Mohammed, Silvio Ligia, Jim Douketis, Chatree Chai‐Adisaksopha, Alfonso Iorio, Davide Matino   +6 more
wiley   +1 more source

Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non-valvular atrial fibrillation

Journal of Arrhythmia, 2015
Background: Activated partial thromboplastin time (aPTT) is recommended for monitoring anticoagulant activity in dabigatran-treated patients; however, there are limited data in Japanese patients.
Daiki Shimomura, Yoshihisa Nakagawa, MD, Hirokazu Kondo, MD, Toshihiro Tamura, MD, Masashi Amano, MD, Yukiko Hayama, MD, Naoaki Onishi, MD, Yodo Tamaki, MD, Makoto Miyake, MD, Kazuaki Kaitani, MD, Chisato Izumi, MD, Masahiko Hayashida, Aya Fukuda, Fumihiko Nakamura, MD, Seiji Kawano, MD   +14 more
doaj   +1 more source

Evaluation of the APTT sensitivity to heparin of five commercial reagents: implications for therapeutic monitoring

, 1998
Heparin is an effective drug for prevention and treatment of thromboembolic conditions. Although several biological assays have been proposed for monitoring unfractionated heparin therapy, the measurement of the activated partial thromboplastin time ...
Manzato F, Grilenzoni A, Mengoni A, LIPPI, Giuseppe   +3 more
core   +1 more source

Optimizing Perioperative Management of Haemophilia B With rFIX‐FP: Pharmacokinetic Validation of the Hemoptidose Tool

Haemophilia, EarlyView.
Abstract Background Surgical management of haemophilia B requires precise factor IX replacement to ensure adequate haemostasis while optimizing factor consumption. Extended half‐life rFIX‐FP simplifies perioperative management but exhibits substantial pharmacokinetic variability.
Xavier Delavenne, Célia Vollard, Nicolas Drillaud, Sabine Castet, Nicolas Luyck, Emilie Hénin, Julien Denis‐Le Seve, Fabienne Volot, Brigitte Tardy, Stéphanie Désage, Benoît Guillet   +10 more
wiley   +1 more source